Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis

被引：0
|
作者：
Xiang Li
Huan Zheng
Man-Cheng Yu
Wei Wang
Xin-Hong Wu
Dong-Mei Yang
Juan Xu
机构：
[1] Huazhong University of Science and Technology,Department of Breast Surgery, Hubei Cancer Hospital, Tongji Medical College
[2] Wuchang Hospital Affiliated to Wuhan University of Science and Technology,Department of Neurology
来源：
Supportive Care in Cancer | 2020年 / 28卷
关键词：
PEGylated G-CSF; G-CSF; Breast cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5085 / 5097
页数：12
相关论文
共 50 条
  • [21] Mobilisation of haemopoetic stem cells with G-CSF after unsuccess with chemotherapy and G-CSF
    Mihaylov, G
    Avramova, B
    Jordanova, M
    Gartcheva, L
    Bobev, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S367 - S367
  • [22] G-CSF alone is superior to chemotherapy plus G-CSF for 2nd mobilization of peripheral blood progenitor cells (PBPC) after failure of adequate mobilization with chemotherapy and G-CSF
    Fraipont, V
    Sautois, B
    Baudoux, E
    Pereira, M
    Fassotte, MF
    Longrée, L
    Jerusalem, G
    Hermanne, JP
    Schaaf-Lafontaine, N
    Sondag, D
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 1999, 23 : S213 - S213
  • [23] Failure of adequate mobilization of peripheral blood progenitor cell (PBPC) with chemotherapy and G-CSF:: G-CSF alone is superior to chemotherapy plus G-CSF for 2nd mobilization.
    Fraipont, V
    Sautois, B
    Baudoux, E
    Pereira, M
    Fassotte, MF
    Jerusalem, G
    Hermanne, JP
    Longrée, L
    Schaaf-Lafontaine, N
    Sondag, D
    Fillet, G
    Beguin, Y
    BLOOD, 1998, 92 (10) : 268A - 268A
  • [24] Pegylated G-CSF Combined with mFOLFIRINOX for Advanced Pancreatic Cancer Patients
    Chen, Peng
    Lei, Jiexin
    Wu, Yue
    Zhou, Benhong
    INTERNAL MEDICINE, 2020, 59 (06) : 877 - 877
  • [25] Kinetics of autologous stem cell mobilization failure: Comparison of AMD3100/G-CSF, G-CSF, GM-/G-CSF, and chemotherapy/G-CSF on remobilization success.
    DiPersio, John F.
    Smith, Angela
    Sempek, Dianne
    Baker, Albert
    Jiang, Steven
    Vij, Ravi
    Cashen, Amanda
    Westervelt, Peter
    BLOOD, 2006, 108 (11) : 965A - 965A
  • [26] Survey for patterns of G-CSF use among cancer patients receiving chemotherapy in Asia
    Mishra, D.
    Wang, L.
    Ho, A.
    H, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 115 - 116
  • [27] Outcomes of G-CSF alone vs G-CSF with upfront plerixafor vs G-CSF/chemotherapy for collection of autologous stem cells in patients with multiple myeloma.
    Talamo, Giampaolo
    George, Melissa
    Ehmann, W. Christopher
    Drabick, Joseph J.
    Mineishi, Shin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Metastatic breast cancer - High doses chemotherapy with G-CSF (filgrastim)
    Temperley, G
    Balbiani, L
    Guzman, M
    Cardoso, C
    Arrieta, S
    Martinez, C
    Comba, AZ
    ANNALS OF ONCOLOGY, 1998, 9 : 30 - 30
  • [29] Proper dosage of primary pegylated G-CSF prophylactic use for breast cancer patients receiving adjuvant or neo-adjuvant chemotherapy.
    Yu, Liang
    Lei, Xin
    Lin, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilization
    Bertolini, F
    Lanza, A
    Peccatori, F
    Zibera, C
    Gibelli, N
    Perotti, C
    Da Prada, GA
    Torretta, L
    Corocchio, E
    Martinelli, G
    della Cuna, GR
    ANNALS OF ONCOLOGY, 1998, 9 (08) : 913 - 916
12345